AMP-activated protein kinase and human cancer: cancer metabolism revisited

被引:83
作者
Kuhajda, F. P. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21201 USA
关键词
carcinogenesis; AMPK activation; cancer metabolism;
D O I
10.1038/ijo.2008.121
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AMP-activated protein kinase (AMPK) and its upstream kinase, LKB1, act to both monitor and restore cellular energy in response to energy depletion. Studied extensively in liver and skeletal muscle, AMPK is phosphorylated and activated by LKB1 in response to increasing AMP/ATP ratios, which occur in a variety of settings including hypoxia, nutrient starvation and redox imbalance. Interest in the roles of both AMPK and LKB1 in cancer has grown substantially, following the identification of LKB1 as the tumor suppressor gene mutated in the Peutz-Jegher familial cancer syndrome. Patients with the Peutz-Jegher syndrome harbor a single inactive LKB1 gene, and acquisition of a second inactivating lesion ( loss of heterozygosity) leads to the development of the cancer in a variety of organs. Thus, the loss of AMPK activation is hypothesized to promote the development of malignancy. Conversely, pharmacological AMPK activation has recently been shown to be cytotoxic to many established human cancer cell lines in vitro and in human cancer xenograft and mouse cancer allografts. Previously, changes in cell metabolism that accompanied the malignant phenotype have largely been considered a consequence of cellular transformation. Now, AMPK and energy metabolism are linked to the development and maintenance of the malignant phenotype. These findings have led to renewed interest in AMPK and cancer cell metabolism in general as potential targets for cancer therapy.
引用
收藏
页码:S36 / S41
页数:6
相关论文
共 45 条
[1]   ATP citrate lyase is an important component of cell growth and transformation [J].
Bauer, DE ;
Hatzivassiliou, G ;
Zhao, FP ;
Andreadis, C ;
Thompson, CB .
ONCOGENE, 2005, 24 (41) :6314-6322
[2]   Increased risk for cancer in patients with the Peutz-Jeghers syndrome [J].
Boardman, LA ;
Thibodeau, SN ;
Schaid, DJ ;
Lindor, NM ;
McDonnell, SK ;
Burgart, LJ ;
Ahlquist, DA ;
Podratz, KC ;
Pittelkow, M ;
Hartmann, LC .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (11) :896-+
[3]  
Boros LG, 2000, CANCER RES, V60, P1183
[4]   The AMP-activated protein kinase cascade - a unifying system for energy control [J].
Carling, D .
TRENDS IN BIOCHEMICAL SCIENCES, 2004, 29 (01) :18-24
[5]   Molecular genetic advances in tuberous sclerosis [J].
Cheadle, JP ;
Reeve, MP ;
Sampson, JR ;
Kwiatkowski, DJ .
HUMAN GENETICS, 2000, 107 (02) :97-114
[6]   5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOSIDE - A SPECIFIC METHOD FOR ACTIVATING AMP-ACTIVATED PROTEIN-KINASE IN INTACT-CELLS [J].
CORTON, JM ;
GILLESPIE, JG ;
HAWLEY, SA ;
HARDIE, DG .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 229 (02) :558-565
[7]   Akt stimulates aerobic glycolysis in cancer cells [J].
Elstrom, RL ;
Bauer, DE ;
Buzzai, M ;
Karnauskas, R ;
Harris, MH ;
Plas, DR ;
Zhuang, HM ;
Cinalli, RM ;
Alavi, A ;
Rudin, CM ;
Thompson, CB .
CANCER RESEARCH, 2004, 64 (11) :3892-3899
[8]   Very high risk of cancer in familial Peutz-Jeghers syndrome [J].
Giardiello, FM ;
Brensinger, JD ;
Tersmette, AC ;
Goodman, SN ;
Petersen, GM ;
Booker, SV ;
Cruz-Correa, M ;
Offerhaus, JA .
GASTROENTEROLOGY, 2000, 119 (06) :1447-1453
[9]   Cortical tuber count: A biomarker indicating neurologic severity of tuberous sclerosis complex [J].
Goodman, M ;
Lamm, SH ;
Engel, A ;
Shepherd, CW ;
Houser, OW ;
Gomez, MR .
JOURNAL OF CHILD NEUROLOGY, 1997, 12 (02) :85-90
[10]   AMP-activated protein kinase: the energy charge hypothesis revisited [J].
Hardie, DG ;
Hawley, SA .
BIOESSAYS, 2001, 23 (12) :1112-1119